A group of Harvard activists has framed GLP-1 weight loss shots as imperialist, The Times reports. The full argument is with the source.
Recap by typeshit. Full story at The Times.
Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.
Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.
He calls GLP-1 drugs useful before surgery or after regain, but says surgery stays the main option for people who need large, lasting weight loss.
An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.
At ASN Kidney Week 2026, the phase 2b data showed lower kidney pressure and kidney fat at 24 weeks, but measured GFR did not change.
eMarketer says weight loss drug brands online need clear pricing and ongoing personal care if they want to hold on to patients.
Loading…